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Outline 
 Economic consequences of production diseases in pigs and poultry 
 Modelling economic consequences of novel solutions to control 
production diseases in pigs and poultry 
• Farm-level modelling 
• Value chain analysis 
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Background 
 Intensive pig and poultry production systems are fairly efficient and 
well-controlled, but the competition is intense, so in order to maintain 
and improve the competitiveness it is essential to enhance the 
control of production diseases 
 Although production diseases can have a substantial impact on farm 
economics, their overall impacts are not very well known. 
 Changes in animal health can have wider societal consequences 
due to contributions to animal welfare and antimicrobial resistance  
 The aim of this presentation is to highlight some of the modelling 
work we have carried out regarding interventions 
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What is financial burden of  
production diseases? 
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Chapter 1 Chapter 2 Chapter 3 Chapter 4 Introduction Methods Resul s Conclusion
Some examples on the significance of diseases 
 
Production diseases can cost up to €30-40 per pig 
 
Necrotic enteritis can cost globally €2 to €5 billion per year  
 
€3 billion is spent each year worldwide to prevent coccidiosis 
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Some examples on the costs of  
production diseases in growing pigs 
 
Production diseases cost money 
- even when the diseases are controlled 
 Examples of the losses of net margin due to production diseases in 
broilers 
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Modelling consequences of novel solutions 
to control production diseases in pigs 
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Dynamic optimisation model for pig fattening 
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Piglet production model accounted for  
events during the farrowing cycle 
(from farrowing to farrowing) 
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Disease associated with poor hygiene 
 Lower growth rate 
 Altered feed consumption 
 Elevated incidence of respiratory lesions 
 Annually, up to 18% less pigmeat per pig space 
 Substantial financial losses, up to €15-23 per pig, 
depending on the scenario, which reduce farm 
income 
 Disease costs correspond to 3-5% of consumer 
price 
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Interventions in broilers 
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Bio-economic modelling 
 Constructed a computer-based optimisation model to explore the 
economic rationale for adoption of health-improving interventions 
 Explored in the project (intervention trials) 
 Other recent trials  
 The scientific literature 
 
 We focussed on trials with data on common leg disorders (FPD) 
 
 Other interventions available in literature – not included 
 Don’t provide productivity data (and/or) 
 Don’t provide data on FPD  
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Types of interventions found 
 Nutritional supplement (Vitamin D) 
 
 Increased bird movement 
 
 Physical separation from floor litter 
 
 Better data on house environmental conditions (to vet & producer) 
 
 12 different interventions in total 
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Impact of treatments on FPD score and net margin 
Control: 18.78 € cents per kg or €4543 per farm (10000 birds) 
Financial consequences of some 
interventions are dependent on the 
scale where they are applied 
Value chain analysis 
18 
Several interventions were addressed 
 Improved hygiene in pig fattening 
 Enhanced care and handling of sows and piglets  
 Increased distance between broiler feeders and drinkers 
 Finland and the UK were used as examples to put these into 
perspective 
 Value chains were characterised 
 Potential impact to farms, consumers and the sector were quantified 
 
Diagram representing a broiler value chain 
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Influences on demand for and prices of pig and poultry products 
 
Estimated farm-level impacts of adoption  
% gross margin and % turnover 
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Interventions can have on business impacts 
 Breeding companies: Market for more robust animals, getting the 
best performance from their products 
 Veterinarians: Selling more advice, testing and systematic visits, less 
treatments 
 Pharmaceutical companies: Market holistic health care protocols 
 Farm workers: more/less work, better job satisfaction 
 Housing and equipment suppliers: Develop new products 
 Finance: reduced credit risk 
 Logistics and slaughtering: Higher quality of products, potential for 
labelled products, potential for more production 
 Retailers: Potential for reduced input price, wider choice of products 
 
 
Three principal economic reasons why  
an intervention can be adopted 
 It reduces production costs per unit of output leading to economic 
gains 
 It increases demand for the product because it contributes valuable 
characteristics which are preferred by the consumers 
 Policy measures or coordinated actions provide additional incentives 
which encourage farmers to adopt the measure 
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Concluding remarks 
 Good hygiene, robust animals and their positive handling and good 
management are examples of interventions which can provide 
efficency gains 
 Interventions are not economically or societally preferred per se, 
because their financial and social viability is dependent on the case 
 Both pig and poultry systems tend to be vertically integrated, this 
provides opportunities to adopt interventions which look at animal 
health from the system perspective.  
 Evidence-based policy is needed to support public policies and 
business decision-making in these sectors.  
 Distribution of value along the supply chain also matters 
 Effective control of production diseases can benefit the consumer! 
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